Category: Finance
-
Brain Signal Synchronization Device in Development
An implantable mental health therapy system is being designed to synchronize signaling rhythms from various regions of the brain.
-
Food Allergy Biotech Acquired for $2.6B
Aimmune Therapeutics Inc., a developer of food allergy drugs, was acquired today by global consumer products company Nestlé for $2.6 billion.
-
Infographic – Biotech Index Cruising in High Range
Looking back to May shows that NBI has largely settled in to the 4,000 to 4,500 range, without volatile swings in either direction.
-
DoD Funding Variable Covid-19 Vaccine Technology
The U.S. Department of Defense is funding work on a Covid-19 vaccine platform that can adjust its formula to protect against future mutations in the virus.
-
Institute Assessing Covid-19 Mental Health Programs
A research institute evaluating real-world health outcomes is funding studies of Covid-19 mental health programs for health care workers and low-income communities.
-
Sanofi Acquires Immune Disease Biotech in $3.7B Deal
A developer of small-molecule therapies for autoimmune diseases, including multiple sclerosis, and other immune disorders is being acquired by Sanofi.
-
Women’s Heart Health Diagnostics in the Works
An organization for redressing health disparities faced by women awarded a new grant to advance better tools for predicting risk of women’s heart disease.
-
Small Biz Grant Advances Neuro Protection Drugs
An NIH award to a biotechnology company funds discovery of drugs that protect brain cells from degenerative disorders like Alzheimer’s disease.
-
A.I. Discovery Company Raises $123M in Venture Funds
A company using image analysis and deep learning to discover therapies for diseases often considered difficult to treat is raising $123 million in new venture funds.
-
Grant Funds Placenta Stem Cell Trial Sites for Covid-19
A clinical trial testing stem cells from human placentas as a treatment for Covid-19 infections is expanding to three more sites in California.